What is the maximum dosing of furosemide (Lasix) for pediatric edema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dosing of Furosemide for Pediatric Edema

For pediatric edema, the maximum recommended dose of furosemide is 10 mg/kg per day, with doses exceeding 6 mg/kg/day not to be given for periods longer than one week to avoid ototoxicity. 1

Dosing Guidelines for Furosemide in Pediatric Edema

Initial Dosing

  • For initial treatment, furosemide can be administered at 0.5-2 mg/kg per dose intravenously or orally 1
  • When given with albumin infusions, consider an intravenous bolus of furosemide (0.5-2 mg/kg) at the end of each albumin infusion in the absence of marked hypovolaemia or hyponatraemia 1
  • For oral maintenance therapy in pediatric patients, the FDA recommends starting at 2 mg/kg body weight as a single dose 2

Dose Escalation and Maximum Dosing

  • Dosing frequency can be increased up to six times daily based on the degree of edema and diuresis achieved 1
  • If diuretic response is not satisfactory after initial dose, dosage may be increased by 1-2 mg/kg no sooner than 6-8 hours after the previous dose 2
  • The maximum recommended dose is 10 mg/kg per day for severe edema 1
  • Doses greater than 6 mg/kg body weight are not recommended for maintenance therapy according to FDA labeling 2
  • High doses of furosemide (>6 mg/kg/day) should not be given for periods longer than 1 week to avoid hearing loss 1

Administration Considerations

  • Infusions should be administered over 5-30 minutes to minimize the risk of ototoxicity 1
  • For maintenance therapy, the dose should be adjusted to the minimum effective level 2
  • In stable patients, furosemide can be given orally at doses of 2-5 mg/kg per day, potentially in combination with a thiazide or potassium-sparing diuretic 1

Monitoring and Safety Considerations

Required Monitoring

  • Adequate monitoring should include assessment of fluid status, electrolytes (particularly for hypokalaemia or hyponatraemia), blood pressure, and kidney function (diuresis and estimated glomerular filtration rate) 1
  • Electrolyte disturbances are the most frequent side effects of high-dose furosemide therapy, especially in patients with gastroenteritis 3

Contraindications and Precautions

  • Furosemide must be stopped in the case of anuria 1
  • Diuretics should be used with caution and only in cases of intravascular fluid overload (evidenced by good peripheral perfusion and high blood pressure) 1
  • Avoid furosemide in patients with marked hypovolaemia, as it could induce or increase hypovolaemia and promote thrombosis 1

Special Considerations for Different Clinical Scenarios

Congenital Nephrotic Syndrome

  • In patients with congenital nephrotic syndrome, diuretics improve edema and fluid control, especially when given with albumin infusions 1
  • If potassium-sparing diuretics are needed, epithelial sodium channel (ENaC) inhibitors like amiloride are preferable to spironolactone 1

Acute Renal Failure

  • In children with acute renal failure, a broad relationship has been observed between single IV dose and diuretic response with furosemide doses ranging from 1.2 to 30.8 mg/kg 3
  • For acute renal failure, it is suggested that the total daily dose should not exceed 100 mg in children 3

Continuous vs. Intermittent Infusion

  • Continuous infusion yields comparable urinary output with a lower total dose of furosemide compared to intermittent administration 4
  • Intermittent administration is associated with greater fluctuations in urinary output and increased fluid replacement needs 4

By following these dosing guidelines and monitoring parameters, furosemide can be safely and effectively used to manage pediatric edema while minimizing the risk of adverse effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.